MTOR and melanoma: Taken together, these results suggest that co-targeting of MEK1/2 and PI3K/mTOR, compared to BRAF and PI3K/mTOR dual blockade, is a more effective approach to rescue susceptibility to caspase-dependent apoptosis in melanoma cells with intrinsic cross-resistant phenotype.